Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03346343 · ClinicalTrials.gov registry record · NA

Pulmonary Function Using Non-invasive Forced Oscillometry

A NA study of Bronchopulmonary Dysplasia and Respiratory Distress Syndrome, Newborn, sponsored by University of Alabama at Birmingham.

Active
Registry status
NA
Development phase
600
Enrollment target
1
Study location

NCT03346343: Active NA study of Bronchopulmonary Dysplasia and Respiratory Distress Syndrome, Newborn, sponsored by University of Alabama at Birmingham.

NCT03346343 is a NA study of Bronchopulmonary Dysplasia and Respiratory Distress Syndrome, Newborn that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 600 participants, above the 216-participant average among 29 other Bronchopulmonary Dysplasia trials with a reported enrollment target (178% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03346343, a NA study of Bronchopulmonary Dysplasia and Respiratory Distress Syndrome, Newborn, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
600 participants
Enrollment target
1
Study location

Study Summary

The purpose of this observational study is to measure pulmonary function in term and preterm infants with and without pulmonary disease including respiratory distress syndrome, bronchopulmonary dysplasia, transient tachypnea of the newborn, meconium aspiration syndrome, and response to treatments given to newborn infants with lung diseases using a non-invasive airway oscillometry system.

Primary Outcome

AXR as the measure of overall measure of reactance of the respiratory system quantified by oscillometry and measured in cmH2O/L

Interventions

  • DEVICE Non-invasive forced airway oscillometry

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2017-12-06
Est. Completion 2027-05
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the registry record for NCT03346343 still lists

NCT03346343 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 216-participant average among 29 other Bronchopulmonary Dysplasia trials with a reported enrollment target (178% higher).

The record links to 6 conditions, with Bronchopulmonary Dysplasia appearing as the primary indexed condition, and to 1 intervention - of which Non-invasive forced airway oscillometry is the first listed.

NCT03346343 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT03346343 about?

NCT03346343 is a clinical study titled "Pulmonary Function Using Non-invasive Forced Oscillometry". The purpose of this observational study is to measure pulmonary function in term and preterm infants with and without pulmonary disease including respiratory distress syndrome, bronchopulmonary dysplasia, transient tachypnea of the newborn, meconium aspiration syndrome, and response to treatments gi...

What is the current status of trial NCT03346343?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2017-12-06. Estimated completion is 2027-05.

What conditions does trial NCT03346343 study?

This clinical trial studies the following conditions: Bronchopulmonary Dysplasia, Respiratory Distress Syndrome, Newborn, Infant, Newborn, Diseases, Infant, Premature, Diseases, Transient Tachypnea of the Newborn.

What interventions are being tested in trial NCT03346343?

The interventions under investigation include: Non-invasive forced airway oscillometry (DEVICE).

Who is sponsoring clinical trial NCT03346343?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03346343 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bronchopulmonary Dysplasia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03346343's enrollment target sits among peer trials

600 3rd of 29 higher than 27 of 29 other Bronchopulmonary Dysplasia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Bronchopulmonary Dysplasia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004317 · 600 participants · Phase 4

    Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

  • NCT00209235 · 600 participants · NA

    Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments

  • NCT01473784 · 600 participants · NA

    Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

  • NCT01866371 · 600 participants

    High Resolution Retinal Imaging

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03346343, the US trial registry maintained by the National Library of Medicine. NCT03346343 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.